Syndecan-4 over-expression preserves cardiac function in a rat model of myocardial infarction

Journal of Molecular and Cellular Cardiology

Volumn 53, Issue 2, 2012, Pages 250-258

  Xie, Jun ^a   Wang, Jingjing ^b   Li, Ruotian ^a   Dai, Qin ^a   Yong, Yonghong ^c   Zong, Bing ^a   Xu, Yunxia ^b   Li, Erguang ^b   Ferro, Albert ^d   Xu, Biao ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Angiogenesis; Cardiac remodeling; Gene therapy; Inflammation; Myocardial infarction

Indexed keywords

ADENOVIRUS VECTOR; ALPHA SMOOTH MUSCLE ACTIN; BRAIN NATRIURETIC PEPTIDE; CD45 ANTIGEN; COLLAGEN TYPE 3; NITRIC OXIDE SYNTHASE; SYNDECAN 4;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR MORTALITY; CELL ACTIVATION; CELL INFILTRATION; CELL LOSS; CONTROLLED STUDY; DISEASE MODEL; DRUG ADMINISTRATION ROUTE; DRUG MECHANISM; ECHOCARDIOGRAPHY; ENDOTHELIUM CELL; GENE; GENE OVEREXPRESSION; GENE THERAPY; HEART; HEART DISEASE; HEART FUNCTION; HEART HEMODYNAMICS; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART PROTECTION; HISTOLOGY; INFLAMMATORY CELL; INTRAMYOCARDIAL DRUG ADMINISTRATION; MALE; MYOCARDITIS; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SYND4 GENE; TREATMENT RESPONSE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; SYNDECAN-4;

ADENOVIRIDAE; MUS; RATTUS;

EID: 84862874555     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.04.014     Document Type: Article

References (40)

1. Fox C.S., Coady S., Sorlie P.D., D'Agostino R.B., Pencina M.J., Vasan R.S., et al. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation Mar. 27 2007, 115(12):1544-1550.
2. Hill J.A., Olson E.N. Cardiac plasticity. N Engl J Med Mar. 27 2008, 358(13):1370-1380.
3. Frantz S., Bauersachs J., Ertl G. Post-infarct remodelling: contribution of wound healing and inflammation. Cardiovasc Res Feb. 15 2009, 81(3):474-481.
4. Ertl G., Frantz S. Healing after myocardial infarction. Cardiovasc Res Apr 1. 2005, 66(1):22-32.
5. Beohar N., Rapp J., Pandya S., Losordo D.W. Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease. J Am Coll Cardiol Oct. 12 2010, 56(16):1287-1297.
6. Takahashi K., Fukushima S., Yamahara K., Yashiro K., Shintani Y., Coppen S.R., et al. Modulated inflammation by injection of high-mobility group box 1 recovers post-infarction chronically failing heart. Circulation Sep. 30 2008, 118(14 Suppl.):S106-S114.
7. Tumova S., Woods A., Couchman J.R. Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions. Int J Biochem Cell Biol Mar. 2000, 32(3):269-288.
8. Finsen A.V., Woldbaek P.R., Li J., Wu J., Lyberg T., Tonnessen T., et al. Increased syndecan expression following myocardial infarction indicates a role in cardiac remodeling. Physiol Genomics Feb. 13. 2004, 16(3):301-308.
9. Matsui Y., Ikesue M., Danzaki K., Morimoto J., Sato M., Tanaka S., et al. Syndecan-4 prevents cardiac rupture and dysfunction after myocardial infarction. Circ Res May 27 2011, 108(11):1328-1339.
10. Lim S.T., Longley R.L., Couchman J.R., Woods A. Direct binding of syndecan-4 cytoplasmic domain to the catalytic domain of protein kinase C alpha (PKC alpha) increases focal adhesion localization of PKC alpha. J Biol Chem Apr. 18 2003, 278(16):13795-13802.
11. Buhligen J., Himmel M., Gebhardt C., Simon J.C., Ziegler W., Averbeck M. Lysophosphatidylcholine-mediated functional inactivation of syndecan-4 results in decreased adhesion and motility of dendritic cells. J Cell Physiol Nov. 2010, 225(3):905-914.
12. Partovian C., Ju R., Zhuang Z.W., Martin K.A., Simons M. Syndecan-4 regulates subcellular localization of mTOR Complex2 and Akt activation in a PKC alpha-dependent manner in endothelial cells. Mol Cell Oct. 2008, 32(1):140-149.
13. Ding L., Dong L., Chen X., Zhang L., Xu X., Ferro A., et al. Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction. Circulation Sep. 1 2009, 120(9):764-773.
14. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A Mar. 3 1998, 95(5):2509-2514.
15. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest Nov. 1973, 52(11):2745-2756.
16. Kwon S., Son H., Choi Y., Lee J.H., Choi S., Lim Y., et al. Syndecan-4 promotes the retention of phosphatidylinositol 4,5-bisphosphate in the plasma membrane. FEBS Lett Jul. 21 2009, 583(14):2395-2400.
17. Araki E., Momota Y., Togo T., Tanioka M., Hozumi K., Nomizu M., et al. Clustering of syndecan-4 and integrin beta1 by laminin alpha 3 chain-derived peptide promotes keratinocyte migration. Mol Biol Cell Jul. 2009, 20(13):3012-3024.
18. Tkachenko E., Elfenbein A., Tirziu D., Simons M. Syndecan-4 clustering induces cell migration in a PDZ-dependent manner. Circ Res Jun. 9 2006, 98(11):1398-1404.
19. Tkachenko E., Lutgens E., Stan R.V., Simons M. Fibroblast growth factor 2 endocytosis in endothelial cells proceed via syndecan-4-dependent activation of Rac1 and a Cdc42-dependent macropinocytic pathway. J Cell Sci Jul. 1 2004, 117(Pt 15):3189-3199.
20. Tkachenko E., Simons M. Clustering induces redistribution of syndecan-4 core protein into raft membrane domains. J Biol Chem May 31 2002, 277(22):19946-19951.
21. Keum E., Kim Y., Kim J., Kwon S., Lim Y., Han I., et al. Syndecan-4 regulates localization, activity and stability of protein kinase C-alpha. Biochem J Mar. 15 2004, 378(Pt 3):1007-1014.
22. Fitzgerald M.L., Wang Z., Park P.W., Murphy G., Bernfield M. Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J Cell Biol Feb. 21 2000, 148(4):811-824.
23. Gotte M. Syndecans in inflammation. FASEB J Apr. 2003, 17(6):575-591.
24. Kon S., Ikesue M., Kimura C., Aoki M., Nakayama Y., Saito Y., et al. Syndecan-4 protects against osteopontin-mediated acute hepatic injury by masking functional domains of osteopontin. J Exp Med Jan. 21 2008, 205(1):25-33.
25. Vanhoutte D., Schellings M.W., Gotte M., Swinnen M., Herias V., Wild M.K., et al. Increased expression of syndecan-1 protects against cardiac dilatation and dysfunction after myocardial infarction. Circulation Jan. 30 2007, 115(4):475-482.
26. Zhang Y., Pasparakis M., Kollias G., Simons M. Myocyte-dependent regulation of endothelial cell syndecan-4 expression. Role of TNF-alpha. J Biol Chem May 21 1999, 274(21):14786-14790.
27. Kojima T., Takagi A., Maeda M., Segawa T., Shimizu A., Yamamoto K., et al. Plasma levels of syndecan-4 (ryudocan) are elevated in patients with acute myocardial infarction. Thromb Haemost May 2001, 85(5):793-799.
28. Weisman H.F., Bush D.E., Mannisi J.A., Weisfeldt M.L., Healy B. Cellular mechanisms of myocardial infarct expansion. Circulation Jul. 1988, 78(1):186-201.
29. Heil M., Schaper W. Pathophysiology of collateral development. Coron Artery Dis Nov. 2004, 15(7):373-378.
30. Ishiguro K., Kadomatsu K., Kojima T., Muramatsu H., Nakamura E., Ito M., et al. Syndecan-4 deficiency impairs the fetal vessels in the placental labyrinth. Dev Dyn Dec. 2000, 219(4):539-544.
31. Jiang Z.S., Srisakuldee W., Soulet F., Bouche G., Kardami E. Non-angiogenic FGF-2 protects the ischemic heart from injury, in the presence or absence of reperfusion. Cardiovasc Res Apr. 1 2004, 62(1):154-166.
32. Korpisalo P., Karvinen H., Rissanen T.T., Kilpijoki J., Marjomaki V., Baluk P., et al. Vascular endothelial growth factor-A and platelet-derived growth factor-B combination gene therapy prolongs angiogenic effects via recruitment of interstitial mononuclear cells and paracrine effects rather than improved pericyte coverage of angiogenic vessels. Circ Res Nov. 7 2008, 103(10):1092-1099.
33. Banquet S., Gomez E., Nicol L., Edwards-Levy F., Henry J.P., Cao R., et al. Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure. Circulation Aug. 30 2011, 124(9):1059-1069.
34. Misra M.K., Sarwat M., Bhakuni P., Tuteja R., Tuteja N. Oxidative stress and ischemic myocardial syndromes. Med Sci Monit Oct. 2009, 15(10):RA209-RA219.
35. Frangogiannis N.G. Targeting the inflammatory response in healing myocardial infarcts. Curr Med Chem 2006, 13(16):1877-1893.
36. Tao Z.Y., Cavasin M.A., Yang F., Liu Y.H., Yang X.P. Temporal changes in matrix metalloproteinase expression and inflammatory response associated with cardiac rupture after myocardial infarction in mice. Life Sci Feb. 6 2004, 74(12):1561-1572.
37. Bai T., Chen C.C., Lau L.F. Matricellular protein CCN1 activates a proinflammatory genetic program in murine macrophages. J Immunol Mar. 15 2010, 184(6):3223-3232.
38. Ishiguro K., Kadomatsu K., Kojima T., Muramatsu H., Iwase M., Yoshikai Y., et al. Syndecan-4 deficiency leads to high mortality of lipopolysaccharide-injected mice. J Biol Chem Dec. 14 2001, 276(50):47483-47488.
39. Xu J., Park P.W., Kheradmand F., Corry D.B. Endogenous attenuation of allergic lung inflammation by syndecan-1. J Immunol May 1 2005, 174(9):5758-5765.
40. Bujak M., Frangogiannis N.G. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res May 1 2007, 74(2):184-195.